Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (461-470 of 1,137) with videos related to

Pageof 114
Sort By:
Journal of the American College of Cardiology|September 1, 2004
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarctionC Michael Gibson, Sabina A Murphy, Ajay J Kirtane, et al.
Placenta|December 3, 2014
Placental SEMA3B expression is not altered in severe early onset preeclampsiaT J Kaitu'u-Lino, R Hastie, P Cannon, et al.
American Heart Journal|June 3, 2008
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines programRajendra H Mehta, Vincent J Bufalino, Wenqin Pan, et al.
Journal of Thrombosis and Thrombolysis|March 27, 2012
Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trialAn H Bui, Marc P Bonaca, Marc S Sabatine, et al.
Cancer|June 12, 2009
Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerusGiri R Gupta, Alan W Yasko, Valerae O Lewis, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2016
Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive MedicationGiuseppe Mancia, Christopher P Cannon, Ilkka Tikkanen, et al.
Open Heart|August 2, 2017
Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trialAndrea Bellavia, Lars Wallentin, Nicola Orsini, et al.
Circulation|April 8, 1998
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9BR A Kloner, T Shook, E M Antman, et al.
The American Journal of Cardiology|February 10, 2019
Simulation of the Impact of Statin Intolerance on the Need for Ezetimibe and/or Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor for Meeting Low-Density Lipoprotein Cholesterol Goals in a Population With Atherosclerotic Cardiovascular DiseaseChristopher P Cannon, Robert J Sanchez, Alexa C Klimchak, et al.
Journal of the American Heart Association|January 7, 2020
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE TrialAbhinav Sharma, Muthiah Vaduganathan, João Pedro Ferreira, et al.
Pageof 114

Showing results (461-470 of 1,137) with videos related to

Sort By:
Pageof 114
Journal of the American College of Cardiology|September 1, 2004
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarctionC Michael Gibson, Sabina A Murphy, Ajay J Kirtane, et al.
Placenta|December 3, 2014
Placental SEMA3B expression is not altered in severe early onset preeclampsiaT J Kaitu'u-Lino, R Hastie, P Cannon, et al.
American Heart Journal|June 3, 2008
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines programRajendra H Mehta, Vincent J Bufalino, Wenqin Pan, et al.
Journal of Thrombosis and Thrombolysis|March 27, 2012
Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trialAn H Bui, Marc P Bonaca, Marc S Sabatine, et al.
Cancer|June 12, 2009
Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerusGiri R Gupta, Alan W Yasko, Valerae O Lewis, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2016
Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive MedicationGiuseppe Mancia, Christopher P Cannon, Ilkka Tikkanen, et al.
Open Heart|August 2, 2017
Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trialAndrea Bellavia, Lars Wallentin, Nicola Orsini, et al.
Circulation|April 8, 1998
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9BR A Kloner, T Shook, E M Antman, et al.
The American Journal of Cardiology|February 10, 2019
Simulation of the Impact of Statin Intolerance on the Need for Ezetimibe and/or Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor for Meeting Low-Density Lipoprotein Cholesterol Goals in a Population With Atherosclerotic Cardiovascular DiseaseChristopher P Cannon, Robert J Sanchez, Alexa C Klimchak, et al.
Journal of the American Heart Association|January 7, 2020
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE TrialAbhinav Sharma, Muthiah Vaduganathan, João Pedro Ferreira, et al.
Pageof 114